Skip Nav Destination
1-4 of 4
Keywords: Non-Hodgkin lymphomaClose
Ximena Camacho, Camila Longo Machado, María Fernanda García, Juan Pablo Gambini, Agustina Banchero, Marcelo Fernández, Natalia Oddone, Daniela Bertolini Zanatta, Carolina Rosal, Carlos Alberto Buchpiguel, Roger Chammas, Eloisa Riva, Pablo Cabral
Oncology (2017) 92 (4): 229–242.
Published Online: 15 February 2017
... antibody approved for the treatment of B-cell non-Hodgkin lymphoma (NHL) expressing CD20 antigen. This antibody has also the potential to be used as a specific fluorescent and radiolabel agent for targeting NHL. Objective: To radiolabel rituximab with technetium-99m ( 99m Tc) or Cy7 and evaluate both...
Li Wu, Tong Wang, Wei Gui, Hualiang Lin, Kaipeng Xie, Hui Wang, Tao Gao, Xiuxiu Zhang, Lei Liu, Ting Han, Yuan Tian, Lifang Hou
Oncology (2014) 87 (1): 40–47.
Published Online: 25 June 2014
...Li Wu; Tong Wang; Wei Gui; Hualiang Lin; Kaipeng Xie; Hui Wang; Tao Gao; Xiuxiu Zhang; Lei Liu; Ting Han; Yuan Tian; Lifang Hou Background and Objective: Elevated serum beta-2 microglobulin (β2-M) has previously been reported in non-Hodgkin lymphoma (NHL) patients. This study examined...
Oncology (1979) 36 (3): 139–143.
Published Online: 10 June 2009
...). The studies were performed on 48 patients with untreated non-Hodgkin lymphoma, 14 Hodgkin patients, 5 patients with lymphadenitis and on 132 controls. In the control group the following percentages of B-T lymphocytes were obtained: blood (n=100): T-68 ± 9, B-20 ± 6, 0-11 ± 7, BT-1 + 1, lymph nodes (n=24): T...
E. Chamorey, R. Gressin, F. Peyrade, J.F. Rossi, G. Lepeu, C. Foussard, J.L. Harrousseau, M. Fabbro, B. Richard, V. Delwail, H. Maisonneuve, J.P. Vilque, A. Thyss
Oncology (2005) 69 (1): 19–26.
Published Online: 01 September 2005
...) with CEOP, a CHOP-like regimen (cyclophosphamide, epirubicin, vincristine and prednisone), in elderly patients (≧65 years) with aggressive non-Hodgkin’s lymphoma (NHL). Methods: One hundred and forty-nine patients were eligible, 72 in the MEMID arm and 77 in the CEOP arm. The primary endpoint was to compare...